Wavelength Pharmaceuticals signs collaboration agreement with Tikun olam-Cannbit for development, manufacturing and marketing of Pharma Grade cGMP cannabis-based active pharmaceutical ingredients (APIs)

Wavelength Pharmaceuticals signs collaboration agreement with Tikun olam-Cannbit for development, manufacturing and marketing of Pharma Grade cGMP cannabis-based active pharmaceutical ingredients (APIs).

Read More